Medication List Nur 106 - Urinary System Disorders

Front 1

Bactrim
trimethoprim/sulfamethoxazole (trye-meth-oh-prim/sul-fa-meth- ox-a-zole)

Back 1

Action: Bactericidal; inhibits the metabolism of folic acid in bacteria; used for UTI and travelers diarrhea
Spectrum: Active against many strains of gram-positive aerobic pathogens
Common side effects: rash, N/V, phlebitis at IV site
Adverse reations: allergic reactions; erythema, stevens-johnson syndrome
Considerations: give w/ full glass of water, never give IM

Front 2

Cipro
ciprofloxacin† (sip-roe-flox-a-sin)

Back 2

Action: Inhibits bacterial DNA synthesis by inhibiting DNA gyrase enzyme; Death of susceptible bacteria
Common side effects: diarrhea, nausea
Adverse reations: seizures, pseudomembranous colitis
Considerations: Observe for signs and symptoms of anaphylaxis (rash, pruritus, laryngeal edema, wheezing). Discontinue drug and notify physician or other health care professional immediately if these problems occur. Keep epinephrine, an antihistamine, and resuscitation equipment close by in case of an anaphylactic reaction.
-Monitor bowel function. Diarrhea, abdominal cramping, fever, and bloody stools should be reported to health care professional promptly as a sign of pseudomembranous colitis. May begin up to several weeks following cessation of therapy.
-Instruct patient to notify health care professional if fever and diarrhea develop, especially if stool contains blood, pus, or mucus. Advise patient not to treat diarrhea without consulting health care professional.
-Instruct patient to notify health care professional immediately if rash, jaundice, signs of hypersensitivity, or tendon (shoulder, hand, Achilles, and other) pain, swelling, or inflammation occur. If tendon symptoms occur, avoid exercise and use of the affected area. Increased risk in >65 yrs old, kidney, heart and lung transplant recipients, and patients taking corticosteroids concurrently. Therapy should be discontinued.

Front 3

levaquin
levofloxacin (le-voe-flox-a-sin)

Back 3

Action: Fluroquinolone; Inhibits bacterial DNA synthesis; Treatment of the following bacterial infections: Urinary tract infections, including cystitis, pyelonephritis, and prostatitis, Respiratory tract infections, including acute sinusitis, acute exacerbations of chronic bronchitis, community-acquired pneumonia, and nosocomial pneumonia, Uncomplicated and complicated skin and skin structure infections. Post-exposure treatment of inhalational anthrax.
Common side effects: nausea
Adverse reactions: heptatoxicity, seizures, arrhythmias, colitis
Considerations: avoid sun exposure, may decrease H&H and glucose in lab results
Instruct patient to notify health care professional if fever and diarrhea develop, especially if stool contains blood, pus, or mucus. Advise patient not to treat diarrhea without consulting health care professional.
Instruct patient to notify health care professional immediately if rash, jaundice, signs of hypersensitivity, or tendon (shoulder, hand, Achilles, and other) pain, swelling, or inflammation occur. If tendon symptoms occur, avoid exercise and use of the affected area. Increased risk in >65 yr old, kidney, heart and lung transplant recipients, and patients taking corticosteroids concurrently. Therapy should be discontinued.